ES2073793T3 - 2-octiniladenosina estable solida y procedimiento para su preparacion. - Google Patents

2-octiniladenosina estable solida y procedimiento para su preparacion.

Info

Publication number
ES2073793T3
ES2073793T3 ES92102210T ES92102210T ES2073793T3 ES 2073793 T3 ES2073793 T3 ES 2073793T3 ES 92102210 T ES92102210 T ES 92102210T ES 92102210 T ES92102210 T ES 92102210T ES 2073793 T3 ES2073793 T3 ES 2073793T3
Authority
ES
Spain
Prior art keywords
solid
octinyladenosine
procedure
preparation
alcoholic solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92102210T
Other languages
English (en)
Inventor
Manami Morozumi
Masao Kumagai
Toyofumi Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Application granted granted Critical
Publication of ES2073793T3 publication Critical patent/ES2073793T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

ESTA INVENCION SUMINISTRA DOS CLASES DE PRODUCTOS DE ENDENOSINA 2-OCTINIL SOLIDAS CON PROPIEDADES NOVELES QUE SON ESTABILIZADOS CON RELACION A LA TEMPERATURA O A LA TEMPERATURA Y HUMEDAD, UNA SIENDO ENDENOSINA 2-OCTINIL SOLIDA CON UN CONTENIDO EN HUMEDAD DE NO MAS DE UN 3%, Y LA OTRA SIENDO ENDENOSINA 2-OCTINIL SOLIDA DEPOSITADA DE UNA SOLUCION ALCOHOLICA ANHIDRA O UNA SOLUCION ALCOHOLICA HIDRATADA DE LA ENDENOSINA 2-OCTINIL, TENIENDO DICHA SOLUCION ALCOHOLICA HIDRATADA UN CONTENIDO EN AGUA MENOR QUE 1%.
ES92102210T 1991-02-12 1992-02-10 2-octiniladenosina estable solida y procedimiento para su preparacion. Expired - Lifetime ES2073793T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3040894A JP2740362B2 (ja) 1991-02-12 1991-02-12 安定な固体状２‐オクチニルアデノシンおよびその製造法

Publications (1)

Publication Number Publication Date
ES2073793T3 true ES2073793T3 (es) 1995-08-16

Family

ID=12593220

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92102210T Expired - Lifetime ES2073793T3 (es) 1991-02-12 1992-02-10 2-octiniladenosina estable solida y procedimiento para su preparacion.

Country Status (7)

Country Link
US (1) US5939543A (es)
EP (1) EP0499185B1 (es)
JP (1) JP2740362B2 (es)
AT (1) ATE122680T1 (es)
CA (1) CA2060865C (es)
DE (1) DE69202483T2 (es)
ES (1) ES2073793T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214807B1 (en) * 1999-06-22 2001-04-10 Cv Therapeutics, Inc. C-pyrazole 2A A receptor agonists
US6180615B1 (en) * 1999-06-22 2001-01-30 Cv Therapeutics, Inc. Propargyl phenyl ether A2A receptor agonists
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US6403567B1 (en) * 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
CA2439222C (en) * 2000-02-23 2009-07-14 Cv Therapeutics, Inc. Identification of partial agonists of the a2a adenosine receptor
WO2004011010A1 (en) * 2002-07-29 2004-02-05 Cv Therapeutics, Inc. Myocardial perfusion imaging using a2a receptor agonists
US20050020915A1 (en) * 2002-07-29 2005-01-27 Cv Therapeutics, Inc. Myocardial perfusion imaging methods and compositions
US8470801B2 (en) 2002-07-29 2013-06-25 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
CA2583185A1 (en) 2004-10-20 2006-04-27 Cv Therapeutics, Inc. Use of a2a adenosine receptor agonists
PL1989214T3 (pl) 2006-02-03 2017-07-31 Gilead Sciences, Inc. Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów
CA2655310A1 (en) * 2006-06-22 2008-05-29 Cv Therapeutics, Inc. Use of a2a adenosine receptor agonists in the treatment of ischemia
US20090081120A1 (en) * 2006-09-01 2009-03-26 Cv Therapeutics, Inc. Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
JP2010502649A (ja) * 2006-09-01 2010-01-28 シーブイ・セラピューティクス・インコーポレイテッド 心筋層画像化法中の患者の耐性を増加させるための方法および組成物
JP2011502101A (ja) * 2006-09-29 2011-01-20 ギリアード・パロ・アルト・インコーポレイテッド 肺疾患の病歴を有する患者における心筋画像化法
EP2099360A2 (en) * 2007-01-03 2009-09-16 CV Therapeutics Inc. Myocardial perfusion imaging
EP2344145A1 (en) * 2008-09-29 2011-07-20 Gilead Sciences, Inc. Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5134443B2 (es) * 1972-10-09 1976-09-27
JPS5140134B2 (es) * 1972-12-27 1976-11-01
JPS50142595A (es) * 1974-05-14 1975-11-17
JPS6299395A (ja) * 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd ２−アルキニルアデノシンおよび抗高血圧剤
DE68916036T2 (de) * 1988-11-15 1994-09-29 Toa Eiyo Ltd Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen.
KR920700218A (ko) * 1989-06-20 1992-02-19 원본미기재 2-알키닐 아데노신의 합성중간체, 그 합성 중간체의 제조법, 그 합성중간체를 이용한 2-알키닐 아데노신의 제조법 및 안정한 2-알키닐 아데노신 유도체
JPH095526A (ja) * 1995-06-14 1997-01-10 Asahi Glass Co Ltd 重畳型ホログラム

Also Published As

Publication number Publication date
EP0499185B1 (en) 1995-05-17
DE69202483T2 (de) 1995-09-28
DE69202483D1 (de) 1995-06-22
CA2060865C (en) 2000-05-16
EP0499185A1 (en) 1992-08-19
US5939543A (en) 1999-08-17
JPH05194579A (ja) 1993-08-03
JP2740362B2 (ja) 1998-04-15
CA2060865A1 (en) 1992-08-13
ATE122680T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
FI854869A0 (fi) Foerfarande foer framstaellning av foerbaettrad kakao.
DE69202483D1 (de) Stabil fest 2-octynyladenozin und Verfahren zu ihrer Herstellung.
BR8804955A (pt) Composto,processo para sua preparacao,composicao e processo para combater ou proteger uma infestacao por insetos e processo para a preparacao de uma composicao
FI895227A7 (fi) Coleoptera-lahkoon tehoavia mikro-organismeja, niihin liittyviä hyönte ismyrkkykoostumuksia ja menetelmiä niiden tuottamiseksi ja käyttämisek si
DK0791571T3 (da) Benzoylderivater
MX9102664A (es) Composiciones termofijas de recubrimiento que tienen dureza mejorada.
BG101893A (en) Nodulosporic acid derivatives
ATE122367T1 (de) Eine feuchtigkeitshärtende einkomponenten- polysiloxanzuzammensetzung.
NO890269L (no) Fremgangsmaate for fremstilling av 1,4-disubstituertepiperidinyl-forbindelser.
ES2142860T3 (es) Composiciones farmaceuticas que contienen gonadotropina, con estabilizador de sacarosa.
DE69202164D1 (de) Stabilisierung von Thiolenzusammensetzungen.
IT8722888A0 (it) Procedimento per la metilazione dicomposti triazinici contenenti gruppi 2,2,6,6tetrametilpiperidinici.
DE68902192D1 (de) Ethylenthioharnstoff enthaltende zusammensetzungen zur herstellung von verschleissfesten, stromlos abgeschiedenen nickel-borueberzuegen.
FI954914A7 (fi) Hyaluronihappoa ja NSAID:tä sisältävät koostumukset angiogeneesin esto n, säätelyn tai regression aikaansaamiseksi
HUP9802956A2 (hu) Gyöngykorom és eljárás előállítására
NO157135C (no) Fremgangsmaate til termisk spalting av 1,2-dikloretan.
EP0300056A4 (en) PROCESS FOR PREPARING TETRAKIS (3-(3,5-DI-tert-BUTYL-4-HYDROXYPHENYL)PROPIONYLOXYMETHYL)METHANE.
EP0192713A4 (en) XENOCOUMACINE.
DE59105287D1 (de) Presse zur Herstellung von Formkörpern aus schüttbarer Masse.
IL88110A0 (en) Di-t-butylphenols substituted by an alkoxy,benzyloxy or benzylthio group and pharmaceutical compositions containing them
EA199900479A1 (ru) Стабилизированные фармацевтические композиции на основе хинупристина и дальфопристина и способ получения
NO156863B (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
FR2684102B1 (fr) Procede de preparation de polyazidoalcools ainsi que de polyaminoalcools et polyazidothiols derives de ceux-ci.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
DE68900131D1 (de) Biozide 4,5-dichlor-1,2-dithiol-3-on-zusammensetzung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 499185

Country of ref document: ES